ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 134 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,457,127 | -28.6% | 1,917,105 | +0.5% | 0.01% | -20.0% |
| Q2 2023 | $53,837,205 | -6.9% | 1,908,444 | -43.2% | 0.01% | -9.1% |
| Q1 2023 | $57,797,659 | -20.7% | 3,360,329 | -7.1% | 0.01% | -26.7% |
| Q4 2022 | $72,876,448 | +7.8% | 3,618,493 | +15.9% | 0.02% | +7.1% |
| Q3 2022 | $67,630,000 | +73.8% | 3,122,364 | +125.5% | 0.01% | +75.0% |
| Q2 2022 | $38,911,000 | +189.4% | 1,384,704 | +375.1% | 0.01% | +300.0% |
| Q1 2022 | $13,447,000 | +4.9% | 291,459 | +91.2% | 0.00% | 0.0% |
| Q4 2021 | $12,815,000 | +42.9% | 152,445 | +13.2% | 0.00% | 0.0% |
| Q3 2021 | $8,970,000 | +91.1% | 134,611 | +52.6% | 0.00% | +100.0% |
| Q2 2021 | $4,693,000 | – | 88,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |